OCUP insider filings
Ocuphire Pharma, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-06-13. Screen OCUP transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for OCUP between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Ocuphire Pharma, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-06-13 | 4 | Rodgers Richard J — Director | Grant/award (A): 41,143 @ $0 · Grant/award (A): 35,181 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Pepose Jay — Director | Grant/award (A): 41,143 @ $0 · Grant/award (A): 35,181 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | MANUSO JAMES S J — Director | Grant/award (A): 41,143 @ $0 · Grant/award (A): 35,181 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Gallagher Cam — Director | Grant/award (A): 41,143 @ $0 · Grant/award (A): 35,181 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Benton Susan — Director | Grant/award (A): 41,143 @ $0 · Grant/award (A): 35,181 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Ainsworth Sean — Director | Grant/award (A): 41,143 @ $0 · Grant/award (A): 35,181 (derivative) @ $0 | EDGAR |
| 2024-05-24 | 4 | Jayagopal Ashwath — Chief Scientific & Dev. Ofc. | Purchase (P): 3,500 @ $1.76 | EDGAR |
| 2024-05-21 | 4 | Magrath George — Chief Executive Officer | Purchase (P): 5,000 @ $1.75 | EDGAR |
| 2024-04-15 | 4 | Pepose Jay — Director | Grant/award (A): 32,000 @ $0 · Grant/award (A): 48,000 (derivative) @ $0 | EDGAR |
| 2024-03-25 | 4 | Jhaveri Nirav S. — Chief Financial Officer | Purchase (P): 10,000 @ $2.10 | EDGAR |
| 2024-03-25 | 4 | SCHACHLE JOSEPH K — Chief Operating Officer | Purchase (P): 2,000 @ $2.05 | EDGAR |
| 2024-03-20 | 4 | Magrath George — Chief Executive Officer | Purchase (P): 25,000 @ $1.96 | EDGAR |
| 2024-02-14 | 4 | Jhaveri Nirav S. — Chief Financial Officer | Grant/award (A): 140,000 @ $0 · Grant/award (A): 210,000 (derivative) @ $0 | EDGAR |
| 2024-02-14 | 4 | Jayagopal Ashwath — Chief Scientific & Dev. Ofc. | Grant/award (A): 75,000 @ $0 · Grant/award (A): 225,000 (derivative) @ $0 | EDGAR |
| 2024-01-22 | 4 | Hoffmann Bernhard — SVP of Corp. Dev. | Grant/award (A): 20,000 @ $0 · Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-01-22 | 4 | Zaremba Rabourn Amy — SVP of Finance | Grant/award (A): 40,000 @ $0 · Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2024-01-12 | 4 | Zaremba Rabourn Amy — SVP of Finance | Tax withholding (F): 3,950 @ $3.27 | EDGAR |
| 2024-01-12 | 4 | Patel Ronil A. — Chief Business Officer | Tax withholding (F): 1,282 @ $3.27 | EDGAR |
| 2024-01-12 | 4 | Hoffmann Bernhard — SVP of Corp. Dev. | Tax withholding (F): 4,031 @ $3.27 | EDGAR |
| 2024-01-03 | 4 | Rodgers Richard J — Director | Grant/award (A): 24,762 | EDGAR |
| 2024-01-03 | 4 | Benton Susan — Director | Grant/award (A): 19,418 | EDGAR |
| 2024-01-03 | 4 | Pepose Jay — Director | Grant/award (A): 14,964 | EDGAR |
| 2024-01-03 | 4 | MANUSO JAMES S J — Director | Grant/award (A): 22,090 | EDGAR |
| 2023-12-05 | 4 | Patel Ronil A. — Chief Business Officer | Grant/award (A): 49,692 @ $0 · Grant/award (A): 74,538 (derivative) @ $0 | EDGAR |
| 2023-11-27 | 4 | SCHACHLE JOSEPH K — Chief Operating Officer | Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2023-11-13 | 4 | Pepose Jay — Director | Grant/award (A): 35,000 @ $0 | EDGAR |
| 2023-11-13 | 4 | Rodgers Richard J — Director | Grant/award (A): 35,000 @ $0 | EDGAR |
| 2023-11-03 | 4 | Magrath George — Chief Executive Officer | Grant/award (A): 400,000 @ $0 · Grant/award (A): 600,000 (derivative) @ $0 | EDGAR |
| 2023-06-08 | 4 | Ainsworth Sean — Director | Grant/award (A): 10,976 @ $0 · Grant/award (A): 9,639 (derivative) @ $0 | EDGAR |
| 2023-06-08 | 4 | MANUSO JAMES S J — Director | Grant/award (A): 10,976 @ $0 · Grant/award (A): 9,639 (derivative) @ $0 | EDGAR |
| 2023-06-08 | 4 | Pepose Jay — Director | Grant/award (A): 10,976 @ $0 · Grant/award (A): 9,639 (derivative) @ $0 | EDGAR |
| 2023-06-08 | 4 | Benton Susan — Director | Grant/award (A): 10,976 @ $0 · Grant/award (A): 9,639 (derivative) @ $0 | EDGAR |
| 2023-06-08 | 4 | Gallagher Cam — Director | Grant/award (A): 10,976 @ $0 · Grant/award (A): 9,639 (derivative) @ $0 | EDGAR |
| 2023-04-26 | 4 | Patel Ronil A. — SVP, Operations & Bus. Dev. | Grant/award (A): 20,000 @ $0 · Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2023-04-21 | 4 | MANUSO JAMES S J — Director | Grant/award (A): 2,819 | EDGAR |
| 2023-04-21 | 4 | Benton Susan — Director | Grant/award (A): 1,053 | EDGAR |
| 2023-04-21 | 4 | Rodgers Richard J — Interim CEO and President, Director | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2023-04-21 | 4 | Pepose Jay — Director | Grant/award (A): 468 | EDGAR |
| 2023-01-12 | 4 | Sooch Mina — President and CEO, Director | Grant/award (A): 134,456 @ $0 · Grant/award (A): 201,683 (derivative) @ $0 | EDGAR |
| 2023-01-12 | 4 | MANUSO JAMES S J — Director | Grant/award (A): 18,544 | EDGAR |
| 2023-01-12 | 4 | Pepose Jay — Director | Grant/award (A): 13,013 · Grant/award (A): 33,291 (derivative) @ $0 | EDGAR |
| 2023-01-12 | 4 | Rodgers Richard J — Director | Grant/award (A): 20,822 | EDGAR |
| 2023-01-12 | 4 | Hoffmann Bernhard — SVP of Corp. Dev. & Ops & Sec. | Grant/award (A): 46,608 @ $0 · Grant/award (A): 69,912 (derivative) @ $0 | EDGAR |
| 2023-01-12 | 4 | Zaremba Rabourn Amy — SVP of Finance | Grant/award (A): 46,608 @ $0 · Grant/award (A): 69,912 (derivative) @ $0 | EDGAR |
| 2023-01-12 | 4 | Benton Susan — Director | Grant/award (A): 16,267 | EDGAR |
| 2023-01-06 | 4 | Gallagher Cam — Director | Option exercise/expiry (X): 1,574 @ $0.00 · Option exercise/expiry (X): 1,574 (derivative) @ $0 | EDGAR |
| 2022-10-20 | 4 | Ainsworth Sean — Director | Option exercise/expiry (X): 1,574 @ $0.00 · Option exercise/expiry (X): 1,574 (derivative) @ $0 | EDGAR |
| 2022-10-12 | 4 | MANUSO JAMES S J — Director | Option exercise/expiry (X): 787 @ $0.00 · Option exercise/expiry (X): 787 (derivative) @ $0 | EDGAR |
| 2022-10-04 | 4 | Rodgers Richard J — Director | Option exercise/expiry (X): 3,148 @ $0.00 · Option exercise/expiry (X): 3,148 (derivative) @ $0 | EDGAR |
| 2022-09-08 | 4 | Sooch Mina — President and CEO, Director | Option exercise/expiry (X): 1,023 @ $0.00 · Option exercise/expiry (X): 1,023 (derivative) @ $0 | EDGAR |
Recent 8-K events — Ocuphire Pharma, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-10 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-21 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-15 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-11 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-09 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-16 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-16 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-24 | 8-K | 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=OCUP returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs